Paul Wachter, Director at Avalanche Biotechnologies, Inc. (AAVL), sold 14,000 shares at $55.46 ($776K) on 2015-01-13, disclosed to the SEC on 2015-01-15.
Open-market sale of $776k AAVL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| [AAVL] | SELL | 2015-06-10 | $46K | — | Filing → |
| [AAVL] | SELL | 2015-06-02 | $43K | — | Filing → |
| [AAVL] | SELL | 2015-05-27 | $44K | — | Filing → |